Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: A multicenter, randomized, double-blind, comparative study

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 12, 2008, Pages 1385-1396

  Arai, Yoichi ^a   Akaza, Hideyuki ^b   Deguchi, Takashi ^c   Fujisawa, Masato ^d   Hayashi, Mikio ^e   Hirao, Yoshihiko ^f   Kanetake, Hiroshi ^g   Naito, Seiji ^h   Namiki, Mikio ⁱ   Tachibana, Masaaki ^j   Usami, Michiyuki ^k   Ohashi, Yasuo ^l  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^f NARA MEDICAL UNIVERSITY   (Japan)

^g NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KYUSHU UNIVERSITY   (Japan)

ⁱ KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^j TOKYO MEDICAL UNIVERSITY   (Japan)

^k OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^l UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Advanced prostate cancer; Bicalutamide; Luteinizing hormone releasing hormone agonist; Maximum androgen blockade; Quality of life

Indexed keywords

BICALUTAMIDE; GOSERELIN; LEUPRORELIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MONOTHERAPY; MULTICENTER STUDY; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; WELLBEING;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; BONE NEOPLASMS; DOUBLE-BLIND METHOD; GONADOTROPIN-RELEASING HORMONE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; NITRILES; PROGNOSIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 54949159478     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0409-z     Document Type: Article

References (21)

1. H Akaza 1999 Prostate cancer therapy and anti-androgens: recent trends Jpn J Urol Surg 12 623 624
2. H Akaza A Yamaguchi T Matsuda 2004 Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients Jpn J Clin Oncol 34 20 28
3. H Akaza H Yoshida Y Takimoto 2005 Bicalutamide 80 mg in combination with an LHRHa versus LHRHa monotherapy in previously untreated advanced prostate cancer: a double-blind, placebo controlled trial J Clin Oncol 23 16S
4. JA Clark BG Bokhour TS Inui RA Silliman JA Talcott 2003 Measuring patients' perceptions of the outcomes of treatment for early prostate cancer Med Care 41 923 936
5. FC Da Silva E Reis T Costa L Denis 1993 Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group Cancer 71 1138 1142
6. F Efficace A Bottomley G van Andel 2003 Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials Cancer 97 377 388
7. MA Eisenberger BA Blumenstein ED Crawford 1998 Bilateral orchiectomy with or without flutamide for metastatic prostate cancer N Engl J Med 339 1036 1042
8. P Esper F Mo G Chodak M Sinner D Cella KJ Pienta 1997 Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument Urology 50 920 928
9. A Hinotsu M Niimi H Akaza 1999 Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: pilot study Gan To Kagaku Ryoho 26 657 666
10. AV Kaisary 1996 Compliance with hormonal treatment for prostate cancer Br J Hosp Med 55 359 366
11. L Klotz P Schellhammer K Carroll 2004 A re-assessment of the role of combined androgen blockade for advanced prostate cancer BJU Int 93 1177 1182
12. WR Lee MC Hall RP McQuellon LD Case DL McCullough 2001 A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy Int J Radiat Oncol Biol Phys 51 614 623
13. MS Litwin DP Lubeck GM Spitalny JM Henning PR Carroll 2002 Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor Cancer 95 54 60
14. DG McLeod ED Crawford BA Blumenstein MA Eisenberger FA Dorr 1992 Controversies in the treatment of metastatic prostate cancer Cancer 70 324 328
15. I Nagakubo M Horiba S Arima T Morikawa S Kato 2002 Assessment of QOL over time in 146 patients treated with radical prostatectomy Jpn J Urol Surg 15 1031 1039
16. Prostate Cancer Trialists' Collaborative Group 2000 Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials Lancet 355 1491 1498
17. PF Schellhammer R Sharifi NL Block MS Soloway PM Venner AL Patterson MF Sarosdy NJ Vogelzang JJ Schellenger GJ Kolvenbag 1997 Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group Urology 50 330 336
18. M Sugiono MH Winkler AA Okeke M Benney DA Gillatt 2005 Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer-a pilot study Prostate Cancer Prostatic Dis 8 91 94
19. M Usami H Akaza Y Arai Y Hirano S Kagawa H Kanetake S Naito Y Sumiyoshi Y Takimoto A Terai H Yoshida Y Ohashi 2007 Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients Prostate Cancer Prostatic Dis 10 194 201
20. Wagner G, Béjin A, Fugl-Meyer AR et al (2000) Symptom score and quality of life. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (eds) Erectile dysfunction. Health Publication Ltd, Plymouth, pp 102-113
21. M Yoshida S Ueda J Machida 1997 Antitumour effect of leuprorelin acetate on prostate cancer and its effect on QOL Jpn J Urol Surg 10 799 807